49.67 USD
▲+0.54+0.28%
盘后 49.55 +0.04%
2026-08-03
市值
$8.33B
市盈率
127.94
EPS
0.39
股息率
—
52 周区间
25.17 – 55.67
成交量
1.43M
Beta
0.29
目标价
56.00
52W 低 25.1752W 高 55.67
价格走势
公司简介
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinical and preclinical product candidates in development for neurological disorders. Its marketed products include ARISTADA, an intramu...